Research Summary
Research Summary
11/29/2024
Miranda Manier, BA
In a randomized controlled study, researchers found that combining pain neuroscience education with motor imagery-based exercises can reduce pain intensity in patients with fibromyalgia and chronic back...
11/29/2024
Research Summary
Research Summary
11/12/2024
Miranda Manier, BA
A recent clinical trial demonstrates that both group and self-paced telehealth mindfulness-based interventions can potentially enhance pain-related function and biopsychosocial outcomes in veterans with...
11/12/2024
Research Summary
Research Summary
10/26/2024
Miranda Manier, BA
Early out-of-bed mobilization enhanced mobility and functional independence in intensive care unit (ICU) patients with moderate-to-severe traumatic brain injury, while also reducing ICU stays and...
10/26/2024
FDA Alert
FDA Alert
10/25/2024
Miranda Manier, BA
The FDA has approved a novel therapy for patients with hemophilia A or B without inhibitors. Clinical trials showed it significantly reduces bleeding episodes by targeting a new protein in the blood...
10/25/2024
Respiratory Diseases Roundup
Respiratory Diseases Roundup
10/24/2024
Anthony Calabro, MA
In this respiratory disease roundup, researchers report on the efficacy of nirmatrelvir-ritonavir for treating Long COVID, the CDC updates recommendations on “triple threat” vaccines for respiratory virus...
10/24/2024
Research Summary
Research Summary
10/18/2024
Miranda Manier, BA
Researchers tested the impact of four different remotely delivered interventions and observed promising effects on several key health outcomes in patients over the age of 50 living with HIV.
10/18/2024
Research Summary
Research Summary
10/08/2024
Anthony Calabro, MA
Breast cancer deaths have fallen by 44% since 1989, according to a new report by the American Cancer Society.
10/08/2024
FDA Alert
FDA Alert
08/19/2024
Anthony Calabro, MA
The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.
08/19/2024
FDA Alert
FDA Alert
07/31/2024
Anthony Calabro, MA
The first orally disintegrating birth control tablet was designed for individuals who have trouble swallowing their medication.
07/31/2024
Roundtable Wrap-Up
Roundtable Wrap-Up
07/19/2024
In this Roundtable Wrap-Up, we offer an abbreviated version of the roundtable discussion on the multidisciplinary approach to managing patients with diabetes and the value of utilizing the services of a...
07/19/2024